SCINTOMICS Molecular, Applied Theranostics Technologies GmbH (SCI-att)
SCINTOMICS Molecular, Applied Theranostics Technologies (SCI-att), is a prominent and fast-growing player in the radiopharmaceutical industry, with a strategic focus on ensuring a consistent supply and comprehensive support for proprietary and innovative tracer technology and non-IP protected precursors. SCI-att stands at the forefront of cutting-edge theranostics solutions. As a subsidiary of Scintomics GmbH, SCI-att took over the prestigious GRP Module Series in 2020, further enhancing our capabilities and product offerings. We are dedicated to expanding our portfolio and providing our customers with an unparalleled portfolio of products and services. At SCI-att, we pride ourselves on delivering top-notch quality and exceptional customer support.
A brief overview of our portfolio
- Fully automated Synthesis modules (GRP®), established worldwide since 18 years
- Precursor e.g. PSMA I&T, HA-DOTATATE, PSMA I&S, siPSMA-14, siFalin-TATE, PSMA-11, DOTA-TOC
- Production Sets (including cassettes, reagents and consumables) for the GRP® module
- Consumables specially adapted for the GRP® Module
SCI-att received the wholesale license and GDP certificate from the German authorities.
We look forward to welcoming you at our booth 1150!